2.535
price down icon7.14%   -0.1949
after-market Handel nachbörslich: 2.56 0.025 +0.99%
loading
Schlusskurs vom Vortag:
$2.7299
Offen:
$2.7429
24-Stunden-Volumen:
95,035
Relative Volume:
0.54
Marktkapitalisierung:
$95.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.27M
KGV:
-15.46
EPS:
-0.164
Netto-Cashflow:
$-7.70M
1W Leistung:
-7.82%
1M Leistung:
+3.47%
6M Leistung:
+136.92%
1J Leistung:
+102.80%
1-Tages-Spanne:
Value
$2.50
$2.7429
1-Wochen-Bereich:
Value
$2.50
$2.7983
52-Wochen-Spanne:
Value
$0.8075
$3.11

Okyo Pharma Limited Stock (OKYO) Company Profile

Name
Firmenname
Okyo Pharma Limited
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-09-30
Name
Neueste SEC-Einreichungen
Name
OKYO's Discussions on Twitter

Vergleichen Sie OKYO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OKYO
Okyo Pharma Limited
2.535 102.67M 0 -13.27M -7.70M -0.164
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Okyo Pharma Limited Aktie (OKYO) Neueste Nachrichten

pulisher
Jul 28, 2025

Should I hold or sell OKYO Pharma Limited stock in 2025Capitalize on market shifts before others do - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does OKYO Pharma Limited compare to its industry peersMaximize your returns with expert insights - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Analyzing OKYO Pharma Limited with risk reward ratio chartsFree Growth Based Stock Signal Screener - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What is OKYO Pharma Limited company’s growth strategyAchieve consistent double-digit returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for OKYO Pharma LimitedTransform your portfolio with high-yield stocks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy OKYO Pharma Limited stockSky-high profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What markets is OKYO Pharma Limited expanding into Is BAYA stock a good long term investment option - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are OKYO Pharma Limited company’s key revenue driversMaximize gains with proven stock analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive OKYO Pharma Limited stock higher in 2025Free Stock Selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in OKYO Pharma Limited stockInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 19:17:36 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is OKYO Pharma Limited Stock During Economic DownturnsFast Moving Stock Alerts - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why OKYO Pharma Limited stock attracts strong analyst attentionMarket Beating Strategy - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How OKYO Pharma Limited stock performs during market volatilityControlled Risk High Reward Plan - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

OKYO Pharma Limited Stock Analysis and ForecastMarket-beating returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about OKYO Pharma Limited stockMassive stock growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying OKYO Pharma Limited stock nowFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will OKYO Pharma Limited stock benefit from AI tech trendsExplosive market performance - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile

Jul 24, 2025
pulisher
Jul 23, 2025

What drives OKYO Pharma Limited stock priceAccelerated wealth expansion - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is OKYO Pharma Limited a good long term investmentPhenomenal trading returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 21, 2025

OKYO Pharma Secures $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain - VisionMonday.com

Jul 21, 2025

Finanzdaten der Okyo Pharma Limited-Aktie (OKYO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Kapitalisierung:     |  Volumen (24h):